References

Agerholm-Larsen, L., A. Raben, N. Haulrik, A.S. Hansen, M. Manders and A. Astrup, 2000. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur. J. Clin. Nutr., 54: 288-297.

Aiba, Y., N. Suzuki, A.M. Kabir, M. Takagi and Y. Koga, 1998. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol., 93: 2097-2101.
PubMed  |  

Arihara, K., H. Ota, M. Itoh, Y. Kondo and T. Sameshima et al., 1998. Lactobacillus acidophilus group lactic acid bacteria applied to meat fermentation. J. Food Sci., 63: 544-547.
CrossRef  |  

Armuzzi, A., F. Cremonini, F. Bartolozzi, F. Canducci and M. Candelli et al., 2001. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment. Pharmacol. Ther., 15: 163-169.

Arunachalam, K., H.S. Gill and R.K. Chandra, 2000. Enhancement of natural immunity function by dietary consumption of Bifidobacterium lactis HN019. Eur. J. Clin. Nutr., 54: 1-4.

Arvola, T., K. Laiho, S. Torkkeli, H. Mykkanen, S. Salminen, L. Maunula and E. Isolauri, 1999. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhoea in children with respiratory infections: A randomized study. Pediatrics, 104: 1-4.
Direct Link  |  

Begley, M., C. Hill and C.G.M. Gahan, 2006. Bile salt hydrolase activity in probiotics. Applied Environ. Microbiol., 72: 1729-1738.
CrossRef  |  Direct Link  |  

Bennet, R., M. Eriksson, C.E. Nord and R. Zetterstrom, 1986. Fecal bacterial microflora of newborn infants during intensive care management and treatment with 5 antibiotic regimens. Pediatr. Infect. Dis., 5: 533-539.

Bernet-Camarad, M.F., V. Lievin, D. Brassart, J.R. Neeser, A.L. Servin and S. Hudault, 1997. The human Lactobacillus acidophilus strain La-1 secrets a non bacteriocin antibacterial substances active in vivo and in vitro. Applied Environ. Microbiol., 63: 2747-2753.

Biller, J.A., A.J. Katz, A.F. Flores, T.M. Buie and S.L. Gorbach, 1995. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J. Pediatr. Gastroenterol. Nutr., 21: 224-226.

Buller, H.A. and R.J. Grand, 1990. Lactose intolerance. Ann. Rev. Med., 41: 141-148.

Canducci, F., A. Armuzzi, F. Cremonini, G. Cammarota and F. Bartolozzi et al., 2000. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment. Pharmacol. Ther., 14: 1625-1629.

Cenci, G., J. Rossi, F. Trotta and G. Caldini, 2002. Lactic acid bacteria isolated from dairy products inhibit genotoxic effect of 4-nitroquinoline-1-oxide in SOS chromotest. Syst. Applied Microbiol., 25: 483-490.

Charteris, W.P., P.M. Kelly, L. Morelli and J.K. Collins, 2002. Edible table (bio) spread containing potentially probiotic Lactobacillus and Bifidobacterium sp. Int. J. Dairy Technol., 55: 44-56.

Coconnier, M.H., M.F. Bernet, S. Kerneis, G. Chauviere, J. Fourniat and A.L. Servin, 1993. Inhibition of adhesion of enteroinvasive pathogens to human intestinal CACO-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett., 110: 299-306.

Coconnier, M.H., V. Lievin, E. Hemery and A.L. Servin, 1998. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Applied Environ. Microbiol., 64: 4573-4580.

Coconnier, M.H., V. Lievin, M.F. Bernet-Camard, S. Hudault and A.L. Servin, 1997. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob. Agents Chemother., 41: 1046-1052.
Direct Link  |  

De Roos, N.M. and M.B. Katan, 2000. Effects of probiotic bacteria on diarrhoea, lipid metabolism and carcinogenesis: A review of papers published between 1988 and 1998. Am. J. Clin. Nutr., 71: 405-411.

De Roos, N.M., G. Schouten and M.B. Katan, 1999. Yoghurt enriched with Lactobacillus acidophilus does not lower blood lipids in healthy men and women with normal to borderline high serum cholesterol levels. Eur. J. Clin. Nutr., 53: 277-280.

De Vrese, M., A. Stegelmann, B. Richter, S. Fenselau, C. Laue and J. Schrezenmeir, 2001. Probiotics-compensation for β-gal insufficiency. Am. J. Clin. Nutr., 73: 421-429.

De Vuyst, L. and E.J. Vandamme, 1994. Antimicrobial Potential of Lactic Acid Bacteria. In: Bacteriocins of Lactic Acid Bacteria, De Vuyst, L. and E.L. Vandamme (Eds.). Blackie Academic and Professional, Glasgow, United Kingdom, pp: 91-142.

Donnet, H.A., F. Rochat, P. Serrant, J.M. Aeschlimann and E.J. Schiffrin, 1999. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: Effective dose. J. Dairy Sci., 82: 863-869.
CrossRef  |  Direct Link  |  

Escherich, T., 1885. Die Darmbakterien des Neugeborenen und Sauglings. Fortschritte der Medizin, 3: 515-522.

FAO. and WHO., 2002. Guidelines for the evaluation of probiotics in food: Report of a joint FAO/WHO expert consultation on guidelines for the evaluation of probiotics in food, London Ontario, Canada, April 30 and May 1, 2002. World Health Organization and Food Agriculture Organization. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.

FAO/WHO, 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina.

Felley, C.P., I. Corthesy-Theulaz, J.L. Rivero, P. Sipponene and B.P. Kaufmann et al., 2001. Favourable effect of acidified milk (LC-1) on Helicobacter gastritis in man. Eur. J. Gastroenterol. Hepatol., 13: 25-29.

Fooks, L.J. and G.R. Gibson, 2002. Probiotics as modulators of the gut flora. Br. J. Nutr., 88: s39-49s.
CrossRef  |  Direct Link  |  

Fujii, A. and E.S. Cook, 1973. Probiotics, antistaphy-lococcal and antifibrinolyticactivities of omega-guanidine acids and omega-guanidinoacyl-L-histidines. J. Med. Chem., 16: 1409-1411.

Fujiwara, S., H. Hashiba, T. Hirota and J.F. Forstner, 1997. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Applied Environ. Microbiol., 63: 506-512.
Direct Link  |  

Fuller, R., 1992. History and Development of Probiotics. In: Probiotics: The Scientific Basis, Fuller, R. (Ed.). Chapman and Hall Publishers, London, pp: 1-8.

Gardiner, G., C. Heinemann, J. Madrenas, A.W. Bruce, D. Beuerman, L. Baroja and G. Reid, 2001. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. Int. Dairy J., 12: 191-196.

Garrity, G.M., J.A. Bell and T.G. Lilburn, 2004. Taxonomic Outline of the Procaryotes Bergey`s Manual of Systematic Bacteriology. 2nd Edn., Springer, New York.

Gill, H.S., K.J. Rutherfurd, J. Prasad and P.K. Gopal, 2000. Enhancement of natural and aquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr., 83: 167-176.

Gill, H.S., M.L. Cross, K.J. Rutherfurd and P.K. Gopal, 2001. Dietary probiotic supplementation to enhance cellular immunity in the elderly. Br. J. Biomed. Sci., 57: 94-96.

Gionchetti, P., F. Rizzello, A. Venturi, P. Brigidi and D. Matteuzzi et al., 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology, 119: 305-309.

Goldin, B.R. and S.L. Gorbach, 1984. The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am. J. Clin. Nutr., 39: 756-761.

Gopal, P.K., J. Prasad, J. Smart and H.S. Gill, 2001. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. Food Microbiol., 67: 207-216.
CrossRef  |  PubMed  |  Direct Link  |  

Gorbach, S.L., T.W. Chang and B. Goldin, 1987. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet, 26: 1519-1519.

Gordon, D., J. Macrae and D.M. Wheater, 1957. A Lactobacillus preparation for use with antibiotics. Lancet, 269: 899-901.

Grigoroff, S., 1905. E`tude sur un lait fermente comestible. Le Kisselo-mleko de Bulgarie. Revue Medical de la Suisse Romande, 25: 714-720.

Guandalini, S., L. Pensabene, M.A. Zikri, J.A. Dias and L.G. Casali et al., 2000. Lactobacillus GG administered in oral rehydration solution to children in acute diarrhoea: A multicenter European trial. J. Pediatr. Gastroenterol. Nutr., 30: 54-60.

Guarino, A., R. Berni Canani, M.I. Spagnuolo, F. Albano and L. Di Benedetto, 1997. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhoea. J. Pediatr. Gastroenterol. Nutr., 25: 516-519.

Gueimonde, M., M. Kalliomaki, E. Isolauri and S. Salminen, 2006. Probiotic intervention in neonates-will permanent colonization ensue? J. Pediatr. Gastroenterol. Nutr., 42: 604-606.

Gupta, P., H. Andrew, B.S. Kirschner, S. Guandalini, 2000. Is Lactobacillus GG helpful in children with Crohn`s disease? Results of a preliminary, open-label study. J. Pediatr. Gastroenterol. Nutr., 31: 453-457.

Gupta, P.K., B.K. Mital and R.S. Gupta, 1995. Antibiotic sensitivity pattern of various Lactobacillus acidophilus strains. Indian J. Exp. Biol., 33: 620-621.
PubMed  |  Direct Link  |  

Hamilton, M.J.M.T., G.R. Gibson and W. Bruck, 2003. Some insight into the derivation and early uses of the word probiotic. Br. J. Nutr., 90: 845-845.

Hatakka, K., E. Savilahti, A. Ponka, J.H. Meurman and T. Poussa et al., 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. Br. Med. J., 322: 1327-1329.

Hatakka, K., E. Savilahti, A. Ponk�, J.H. Meurman and T. Poussa et al., 2001. Effect of long term con sumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. Br. Med. J., 322: 1327-1329.

Havenaar, R. and J.H.J. Huis in't Veld, 1992. Probiotics: A General View. In: The Lactic Acid Bacteria: The Lactic Acid Bacteria in Health and Disease, Wood, B.J. (Ed.). Vol. 1, Elsevier Applied Science, London, pp: 151-170.

Herter, C.A. and A.I. Kendall, 1908. An observation on the fate of B. bulgaricus in the digestive tract of a monkey. J. Bacteriol., 5: 293-302 (In Bacillac).

Hertzler, S.R. and S.M. Clancy, 2003. Kefir improves lactose digestion and tolerance in adults with lactose maldigestion. J. Am. Dietetic Assoc., 103: 582-587.
CrossRef  |  Direct Link  |  

Hilton, E., H.D. Isenberg, P. Alperstein, K. France and M.T. Borenstein, 1992. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann. Int. Med., 116: 353-357.
PubMed  |  Direct Link  |  

Hilton, E., P. Kolakowski, C. Singer and M. Smith, 1997. Efficacy of Lactobacillus GG as a diarrheal preventive in travellers. J. Travel. Med., 4: 41-43.
PubMed  |  Direct Link  |  

Hilton, E., P. Rindos and H.D. Isenberg, 1995. Lactobacillus GG vaginal suppositories and vaginitis. J. Clin. Microbiol., 33: 1433-1433.
Direct Link  |  

Hirayama, K. and J. Rafter, 2000. The role of probiotic bacteria in cancer prevention. Microbes Infect., 2: 681-686.
CrossRef  |  PubMed  |  Direct Link  |  

Holm, F., 2003. Gut health and diet: The benefits of probiotic and prebiotics onhuman health. World Ingredients, 2: 52-55.

Holzapfel, W.H., P. Haberer, J. Snel, U. Schillinger and J.H.J.H. Veld, 1998. Overview of gut flora and probiotics. Int. J. Food Microbiol., 41: 85-101.
CrossRef  |  PubMed  |  Direct Link  |  

Holzapfel, W.H., P. Haberer, R. Geisen, J. Bjorkroth and U. Schillinger, 2001. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am. J. Clin. Nutr., 73: 365S-373S.
PubMed  |  Direct Link  |  

Hoyos, A.B., 1999. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int. J. Infect. Dis., 3: 197-202.
PubMed  |  Direct Link  |  

Hudault, S., V. Lievin, M.F. Bernet-Camard and A.L. Servin, 1997. Antagonistic activity in vitro and in vivo exerted by Lactobacillus casei (strain GG) against Salmonella typhimurium infection. Applied Environ. Microbiol., 63: 513-518.

Ishibashi, N. and S. Yamazaki, 2001. Probiotics and safety. Am. J. Clin. Nutr., 73: 465-470.
Direct Link  |  

Isolauri, E., A.C. Ouwehand and K. Laitinen, 2005. Novel approaches to the nutritional management of the allergic infant. Acta Paediatrica Suppl., 94: 110-114.

Isolauri, E., J. Joensuu, H. Suomalainen, M. Luomala and T. Vesikari, 1995. Improved immunogenicity of oral D 3 RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine, 13: 310-312.

Isolauri, E., M. Juntunen, T. Rautanen, P. Sillanaukee and T. Koivula, 1991. A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhoea in children. Pediatrics, 88: 90-97.

Kaila, M., E. Isolauri, E. Soppi, E. Virtanen, S. Laine and H. Arvilommi, 1992. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res., 32: 141-144.
PubMed  |  

Kailasapathy, K. and J. Chin, 2000. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol., 78: 80-88.
CrossRef  |  Direct Link  |  

Kalliomaki, M. and E. Isolauri, 2003. Role of intestinal flora in the development of allergy. Curr. Opin. Allergy Clin. Immunol., 3: 15-20.

Khalil, A.H. and E.H. Mansour, 1998. Alginate encapsulated bifidobacteria survival in mayonnaise. J. Food Sci., 63: 702-705.

Kolb, H., 1955. Die Behandlung acuter infekte unter dem Gesichtswinkel der prophylaxe chronischer Leiden. Uber die Behandlung mit physiologischen bakterien. Microecol. Ther., 1: 15-19.

Kollath, W., 1953. Nutrition and the tooth system: General review with specialreference to vitamins. Deutsche Zahnarztliche Zeitschrift, 8: 7-16.

Kosikowski, F. and V.V. Mistry, 1997. Cheese and fermented milk foods-origins and principles. Wesport, CT., USA: F V Kosikowksi Llc, 1: 87-108.

Langhendries, J.P., J. Detry and J. Van Hees, 1995. Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants. J. Pediatr. Gastroenterol. Nutr., 21: 177-181.

Lankaputhra, W.E.V. and N.P. Shah, 1998. Antimutagenic properties of probiotic bacteria and of organic acids. Mutat. Res., 397: 169-182.

Lewis, S.J. and S. Burmeister, 2005. A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. Eur. J. Clin. Nutr., 59: 776-780.

Lilly, D.M. and R.H. Stillwell, 1965. Probiotics: Growth-promoting factors produced by microorganisms. Science, 147: 747-748.

Liong, M.T. and N.P. Shah, 2005. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J. Dairy Sci., 88: 55-66.
CrossRef  |  Direct Link  |  

Liong, M.T. and N.P. Shah, 2005. Optimization of cholesterol removal, growth and fermentation patterns of Lactobacillus acidophilus ATCC 4962 in the presence of mannitol, fructo-oligosaccharide and inulin: A response surface methodology approach. J. Applied Microbiol., 98: 1115-1126.

Liong, M.T. and N.P. Shah, 2006. Effects of Lactobacillus casei ASCC 292, fructooligosaccharide and maltodextrin on serum lipid profiles, intestinal microflora and organic acids concentration in rats. J. Dairy Sci., 89: 1390-1399.

Lo, P.R., R.C. Yu, C.C. Chou and E.C. Huang, 2004. Determinations of the antimutagenic activities of several probiotic bifidobacteria under acidic and bile conditions against benzo(a)pyrene by a modified Ames test. Int. J. Food Microbiol., 93: 249-257.

Mack, D.R., S. Michail, S. Wei, L. McDougall and M.A. Hollingsworth, 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. Gastrointest. Liver Physiol., 276: 941-950.
CrossRef  |  PubMed  |  Direct Link  |  

Majamaa, H., E. Isolauri, M. Saxelin and T. Vesikari, 1995. Lactic acid bacteria in thetreatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr., 20: 333-338.

Mann, G.V. and A. Spoerry, 1974. Studies of a surfactant and cholesteremia in the Maasai. Am. J. Clin. Nutr., 27: 464-469.

Marteau, P., 2001. Safety aspect of probiotic products. Scand. J. Nutr., 45: 22-24.

Martini, M.C. and D.A. Savaiano, 1988. Reduced intolerance symptoms from lactose consumed during a meal. Am. J. Clin. Nutr., 47: 57-60.

Matsuzaki, T. and J. Chin, 2000. Modulating immune responses with probiotic bacteria. Immunol. Cell. Biol., 78: 67-73.
CrossRef  |  Direct Link  |  

Matteuzzi, D., F. Crociani and P. Brigidi, 1983. Antimicrobial susceptibility of Bifidobacterium. Ann. Microbiol., 134A: 339-349.
CrossRef  |  Direct Link  |  

Mattila-Sandholm, T., P. Myllarinen, R. Crittenden, G. Mogensen, R. Fonden and M. Saarela, 2002. Technological challenges for future probiotic foods. Int. Dairy J., 12: 173-182.
CrossRef  |  Direct Link  |  

Metchnikoff, E., 1907. In the Prolongation of Life. In: Optimistic Studies, Chalmers, M. (Ed.). William Heinemann, London.

Metchnikoff, I.I., 2004. The Prolongation of Life: Optimistic Studies. Springer, New York, USA.

Michetti, P., G. Dorta, P.H. Wiesel, D. Brassart and E. Verdu et al., 1999. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion, 60: 203-209.

Midolo, P.D., J.R. Lambert, R. Hull, F. Luo and M.L. Grayson, 1995. In vitro inhibition of H. pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Applied Bacteriol., 79: 475-479.

Miettinen, M., A. Lehtonen, I. Julkunen and S. Matikainen, 2000. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J. Immunol., 164: 3733-3740.

Mitsuoka, T., 1992. The human gastrointestinal tract. Lactic Acid Bacteria, 1: 69-114.

Montalto, M., G. Nucera, L. Santoro, V. Curigliano and M. Vastola et al., 2005. Effect of exogenous β-galactosidase in patients with lactose malabsorption and intolerance: A crossover double-blind placebo-controlled study. Eur. J. Clin. Nutr., 59: 489-493.

Morelli, L., 2007. In vitro assessment of probiotic bacteria: From survival to functionality. Int. Dairy J., 17: 1278-1283.

Moro, E., 1905. Morphologische und biologische Untersuchung uber dei Darmbakterien des Sauglings. Jahrbuch Kinderheilkunde Physiche Erziehung, 61: 687-734.

Moro, E., 1990. U ber den Bacillus acidophilus. Jahrbuch Kinderheilkunde Physiche Erziehung, 52: 38-55.

Moubareck, C., F. Gavini, L. Vaugien, M.J. Butel and F.D. Populaire, 2005. Antimicrobial susceptibility of bifidobacteria. J. Antimicrob. Chemother., 55: 38-44.
CrossRef  |  Direct Link  |  

Ogawa, M., K. Shimizu, K. Nomoto, M. Takahashi and M. Watanuki et al., 2001. Protective effect of Lactobacillus casei strain shirota on shiga toxin-producing Escherichia coli O157: H7 infection in infant rabbits. Infect. Immunol., 69: 1101-1108.
PubMed  |  

Ohashi, Y., 2000. Control study for bladder cancer prevention: Habitual intake of lactic acid bacteria prevents occurrence of bladder cancer. Proceedings of 2nd International Congress on Probiotics, Guadalajara, Mexico.

Ong, L., A. Henriksson and N.P. Shah, 2006. Development of probiotic Cheddar cheese containing Lactobacillus acidophilus, L. casei, L. paracasei and Bifidobacterium sp. and the influence of these bacteria on proteolytic patterns and production of organic acid. Int. Dairy J., 16: 446-456.
CrossRef  |  

Orrhage, K., E. Sillerstrom, J.A. Gustafsson, C.E. Nord and J. Rafter, 1994. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat. Res., 311: 239-248.
PubMed  |  Direct Link  |  

Ouwehand, A.C., E. Isolauri, F. He, H. Hashimoto, Y. Benno and S. Salminen, 2001.. Differences in Bifidobacterium flora composition in allergic and healthy infants. J. Allergy Clin. Immunol., 108: 144-145.

Ouwehand, A.C., P.V. Kirjavainen, C. Shortt and S. Salminen, 1999. Probiotics: Mechanisms and established effects. Int. Dairy J., 9: 43-52.
CrossRef  |  Direct Link  |  

Oxman, T., M. Shapira, R. Klein, N. Avazov and B. Rabinowitz, 2001. Oral administration of Lactobacillus induces cardioprotection. J. Altern. Complement. Med., 7: 345-354.

Parker, R.B., 1974. Probiotics, the other half of the story. Anim. Nutr. Health, 29: 4-8.

Perdigon, G., E. Vintini, S. Alvarez M. Medina and M. Medici, 1999. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci., 82: 1108-1114.
CrossRef  |  PubMed  |  Direct Link  |  

Perdone, C.A., A.O. Bernabeu, E.R. Postaire, C.F. Bouley and P. Reinert, 1999. The effect of supplementation by Lactobacillus casei (strain DN-114 001) on accute diarrhoea in children attending day care centers. Int. J. Clin. Pract., 53: 179-184.

Rafter, J., 2002. Lactic acid bacteria and cancer: Mechanistic perspective. Br. J. Nutr., 88: 89-89.

Reid, G., 1999. The scientific basis for probiotic strains of Lactobacillus. Applied Environ. Microbiol., 65: 3763-3766.
Direct Link  |  

Reid, G., A.W. Bruce and M. Taylor, 1995. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol. Ther., 23: 32-45.

Reid, G., A.W. Bruce, N. Fraser, C. Heinemann, J. Owen and B. Henning, 2001. Oral probiotics can resolve urogenital infections. FEMS Microbiol. Immunol., 30: 49-52.
CrossRef  |  Direct Link  |  

Reid, G., D. Beuerman, C. Heinemann and A.W. Bruce, 2001. Effect of oral probiotic Lactobacillus therapy on the vaginal flora and susceptibility to urogenital infections. FEMS Immunol. Med. Microbiol., 32: 37-41.

Rettger, L.F. and G.D. Horton, 1914. A comparative study of the intestinal flora of white rats kept on experimental and ordinary mixed diets. Zentralblatt Bakteriologie Parasitenkunde, 73: 362-372.

Rettger, L.F. and H.A. Cheplin, 1920. The transformation of the intestinal flora, with special reference to the implantation of Bacillus acidophilus. I. Feeding experiments with albino rats. Proc. Natl. Acad. Sci. USA., 6: 423-426.

Rettger, L.F. and H.A. Cheplin, 1920. The transformation of the intestinal flora, with special reference to the implantation of Bacillus acidophilus. II. Feeding experiments on man. Proc. Natl. Acad. Sci. USA., 6: 704-705.

Rolfe, R.D., 2000. The role of probiotic cultures in the control of gastrointestinal health. J. Nutr., 130: 396S-402S.
Direct Link  |  

Saavedra, J.M., N.A. Bauman, I. Oung, J.A. Perman and R.H. Yolken, 1994. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet, 334: 1046-1049.

Salminen, M.K., H. Rautelin, S. Tynkkynen, T. Poussa, M. Saxelin, V. Valtonen and A. Jarvinen, 2006. Lactobacillus bacteremia, species identification and antimicrobial susceptibility of 85 blood isolates. Clin. Infect. Dis., 42: 35-44.
PubMed  |  Direct Link  |  

Salminen, S., A. Ouwehand, Y. Benno and Y.K. Lee, 1999. Probiotics: How should they be defined? Trends Food Sci. Technol., 10: 107-110.
CrossRef  |  Direct Link  |  

Salminen, S., E. Isolauri and E. Salminen, 1996. Clinical uses of probiotics for stablising gut mucosal barrier: Successful strains and future challenges. Antonie Van Leeuwenhoek, 70: 347-358.
CrossRef  |  PubMed  |  

Schaafsma, G., 1996. State-of-the-art concerning probiotic strains in milkproducts. IDF Nutr. Newslett., 5: 23-24.

Schrezenmeir, J. and M. de Vrese, 2001. Probiotics, prebiotics and synbiotics-approaching a definition. Am. J. Clin. Nutr., 73: 361S-364S.
PubMed  |  Direct Link  |  

Scrimshaw, N.S. and E.B. Murray, 1988. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am. J. Clin. Nutr., 48: 1142-1159.
CrossRef  |  PubMed  |  Direct Link  |  

Shah, N.P., 2006. Functional cultures and health benefits. Proceedings of the IDF Symposium on Scientific and Technological Challenges in Fermented Milk/IDF Dairy Science and Technology Week, May 15-19, Sirmione, Italy, pp: 35-36.

Shah, N.P., 2004. Probiotics and prebiotics. Agro Food Ind. Hi-Tech, 15: 13-16.
Direct Link  |  

Shanahan, F., 2000. Probiotics and inflammatory bowel disease: Is there a scientific rationale? Inflamm. Bowel Dis., 6: 107-115.

Sheih, Y.H., B.L. Chiang, L.H. Wang, L.K. Chuh and H.S. Gill, 2001. Systemic immunityenhancing effect in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr., 20: 149-156.

Shornikova, A.V., E. Isolauri, L. Burkanova, S. Lukovnikova and T. Vesikari, 1997. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr., 86: 460-465.

Shu, Q., H. Lin, K.J. Rutherfurd, S.G. Fenwick, J. Prasad, P.K. Gopal and H.S. Gill, 2000. Dietary B. lactis HN019 enhances resistance to oral Salmonella typhimurium infection in mice. Microbiol. Immunol., 44: 213-222.

Sieber, R. and U.T. Dietz, 1998. Lactobacillus acidophilus and yogurt in the prevention and therapy of bacterial vaginosis. Int. Dairy J., 8: 599-607.

Sperti, G.S., 1971. Probiotics. Avi Publishing Co., Westpoint, CT, USA., pp: 121.

Steer, T., H. Carpenter, K. Tuohy and G.R. Gibson, 2000. Perspectives on the role of the human gut microbiota and its modulation by pro-and prebiotics. Nutr. Res. Rev., 13: 229-254.

Szajewska, H., M. Kotowska, J.Z. Mrukowicz, M. Armanska and W. Mikolajczyk, 2001. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhoea in infants. J. Pediatr., 138: 361-365.

Tanaka, H., K. Doesburg, T. Iwasaki and I. Mireau, 1999. Screening of lactic acid bacteria for bile salt hydrolase activity. J. Dairy Sci., 82: 2530-2535.
CrossRef  |  Direct Link  |  

Tannock, G.W., K. Munro, H.J. Harmsen, G.W. Welling, J. Smart and P.K. Gopal, 2000. Analysis of fecal microflora of human subjects subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Applied Environ. Microbiol., 66: 2578-2588.

Tavan, E., C. Cayuela, J.M. Antoine and P. Cassand, 2002. Antimutagenic activities of various lactic acid bacteria against food mutagens: Heterocyclic amines. J. Dairy Res., 69: 335-341.

Tharmaraj, N. and N.P. Shah, 2004. Survival of Lactobacillus acidophilus, Lactobacillus paracasei subsp. paracasei, Lactobacillus rhamnosus, bifidobacterium animalis and Propionibacterium in cheese-based dips and the suitability of dips as effective carriers of probiotic bacteria. Int. Dairy J., 14: 1055-1066.

Tissier, H., 1908. Recherches sul la flore intestinale nomrale des enfants ages dun an a cinans. Ann. PInstitute Pasteur, 22: 189-207.

Tuohy, K.M., H.M. Probert, C.W. Smejkal and G.R. Gibson, 2003. Using probiotics and prebiotics to improve gut health. Drug Discovery Today, 8: 692-700.
Direct Link  |  

Vanderhoof, J.A., D.B. Whitney, D.L. Antonson, T.L. Hanner, J.V. Lupo and R.J. Young, 1999. Lacto bacillus GG in the prevention of antibiotic-associated diarrhoea in children. J. Pediatr., 135: 564-568.

Vergin, F., 1954. Anti und Probiotika. Hippokrates, 25: 116-119.

Vesa, T.H., P. Marteau, S. Zidi, F. Briet, P. Pochart and J.C. Rambaud, 1996. Digestion and tolerance of lactose from yoghurt and different semi-solid fermented dairy products containing Lactobacillus acidophilus and bifidobacteria in lactose maldigesters-is bacterial lactase important? Eur. J. Clin. Nutr., 50: 730-733.

Viljanen, M., E. Savilahti, T. Haahtela, K. Juntunen-Backman and R. Korpela et al., 2005. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A double-blind placebo-controlled trial. Allergy, 60: 494-500.

Viljanen, M., M. Kuitunen, T. Haahtela, K. Juntunen-Backman, R. Korpela and E. Savilahti, 2005. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr. Allergy Immunol., 16: 65-71.

Vuaghan, E.E., H.G.H.J. Heilig, K. Ben-Amor and W. De Vos, 2005. Diversity, vitality and activities of intestinal lactic acid bacteria and Bifidobacteria assessed by molecular approaches. FEMS Microbiol. Rev., 29: 477-490.

WHO, 1995. The treatment of diarrhoea. A Manual for Physicians and Other Senior Health Workers. WHO/CDR/95.3.

Yakult, 1998. Central Institute for Microbiological Research, Lactobacillus Cases Strain Shirota. Yakult Honsha Co. Ltd., Tokyo, Japan.

Yazdanbakhsh, M., P.G. Kremsner and R. Van Ree, 2002. Allergy, parasites and the hygiene hypothesis. Science, 296: 490-494.